Oral Administration or Nasal Feeding of Huzhangxiefei Decoction for Treatment in Sepsis Induced Acute Lung Injury

NCT04940676 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Acute Lung Injury
Sepsis

Interventions

DRUG: Huzhangxiefei Decoction
DRUG: 10% Huzhangxiefei Decoction

Sponsor

Xinhua Hospital, Shanghai Jiao Tong University School of Medicine